Characterization of muscarinic autoreceptors in the rabbit hippocampus and caudate nucleus

Neurochemical Research

Volumn 28, Issue 3-4, 2003, Pages 413-417

  Stoll, C ^a   Schwarzwalder U ^a   Johann, S ^a   Lambrecht, G ^b   Hertting, G ^a   Feuerstein, T J ^a   Jackisch, R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Acetylcholine release; Muscarinic autoreceptor; Rabbit caudate nucleus; Rabbit hippocampus

Indexed keywords

11 [[4 [4 (DIETHYLAMINO)BUTYL] 1 PIPERIDYL]ACETYL] 5,11 DIHYDRO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPIN 6 ONE; 3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; CHOLINE; GENE PRODUCT; HEXAHYDROSILADIFENIDOL; HIMBACINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; OXOTREMORINE; PIRENZEPINE; TRIPINAMIDE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACETYLCHOLINE; ANIMALS; AUTORECEPTORS; CAUDATE NUCLEUS; CHOLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HIPPOCAMPUS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; OSMOLAR CONCENTRATION; OXOTREMORINE; RABBITS; RECEPTORS, MUSCARINIC;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS; ORYCTOLAGUS CUNICULUS;

EID: 0346665953     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022836315383     Document Type: Article

References (30)

1. Caulfield, M. P. and Birdsall, N. J. 1998. International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50:279-290.
2. Grimm, U., Moser, U., Mutschler, E., and Lambrecht, G. 1994. Muscarinic receptors: Focus on presynaptic mechanisms and recently developed novel agonists and antagonists. Pharmazie 49: 711-726.
3. Zhang, W., Basile, A. S., Gomeza, J., Volpicelli, L. A., Levey, A. I., and Wess, J. 2002. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J. Neurosci. 22:1709-1717.
4. Doležal, V. and Tuček, S. 1998. The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists. Br. J. Pharmacol. 124:1213-1218.
5. McKinney, M., Miller, J. H., and Aagaard, P. J. 1993. Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. J. Pharmacol. Exp. Ther. 264:74-78.
6. Marchi, M. and Raiteri, M. 1989. Interaction acetylcholineglutamate in rat hippocampus: Involvement of two subtypes of M-2 muscarinic receptors. J. Pharmacol. Exp. Ther. 248: 1255-1260.
7. Richards, M. H. 1990. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: Comparison with hippocampal M1, atrial M2 and ileal M3 receptors. Br. J. Pharmacol. 99:753-761.
8. Wall, S. J., Wolfe, B. B., and Kromer, L. F. 1994. Cholinergic deafferentation of dorsal hippocampus by fimbria-fornix lesioning differentially regulates subtypes (m1-m5) of muscarinic receptors. J. Neurochem. 62:1345-1351.
9. Kitaichi, K., Day, J. C., and Quirion, R. 1999. A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type. Eur. J. Pharmacol. 383:53-56.
10. Kitaichi, K., Hori, T., Srivastava, L. K., and Quirion, R. 1999. Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus. Brain Res. Mol. Brain Res. 67:98-106.
11. Billard, W., Binch, H., 3rd, Crosby, G., and McQuade, R. D. 1995. Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data. J. Pharmacol. Exp. Ther. 273:273-279.
12. Lapchak, P. A., Araujo, D. M., Quirion, R., and Collier, B. 1989. Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices. Brain Res. 496:285-294.
13. De Boer, P., Westerink, B. H., Rollema, H., Zaagsma, J., and Horn, A. S. 1990. An M3-like muscarinic autoreceptor regulates the in vivo release of acetylcholine in rat striatum. Eur. J. Pharmacol. 179:167-172.
14. Raiteri, M., Marchi, M., and Paudice, P. 1990. Presynaptic muscarinic receptors in the central nervous system. Ann. N. Y. Acad. Sci. 604:113-129.
15. Vizi, E. S., Kobayashi, O., Torocsik, A., Kinjo, M., Nagashima, H., Manabe, N., Goldiner, P. L., Potter, P. E., and Foldes, F. F. 1989. Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release. Neuroscience 31: 259-267.
16. James, M. K. and Cubeddu, L. X. 1987. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum. J. Pharmacol. Exp. Ther. 240:203-215.
17. Mash, D. C., Flynn, D. D., and Potter, L. T. 1985. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228: 1115-1117.
18. Quirion, R., Wilson, A., Rowe, W., Aubert, I., Richard, J., Doods, H., Parent, A., White, N., and Meaney, M. J. 1995. Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. J. Neurosci. 15:1455-1462.
19. Bolognesi, M. L., Minarini, A., Budriesi, R., Cacciaguerra, S., Chiarini, A., Spampinato, S., Tumiatti, V., and Melchiorre, C. 1998. Universal template approach to drug design: Polyamines as selective muscarinic receptor antagonists. J. Med. Chem. 41: 4150-4160.
20. Augelli-Szafran, C. E., Jaen, J. C., Moreland, D. W., Nelson, C. B., Penvose-Yi, J. R., and Schwarz, R. D. 1998. Identification and characterization of M4 selective muscarinic antagonists. Bioorg. Med. Chem. Lett. 8:1991-1996.
21. Hertting, G., Zumstein, A., Jackisch, R., Hoffmann, I., and Starke, K. 1980. Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn Schmiedebergs Arch. Pharmacol. 315:111-117.
22. Jackisch, R., Strittmatter, H., Kasakov, L., and Hertting, G. 1984. Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch. Pharmacol. 327:319-325.
23. Altman, D. G. 1991. Statistics in medical journals: Developments in the 1980s. Stat. Med. 10:1897-1913.
24. Gardner, M. J. and Altman, D. G. 1986. Confidence intervals rather than P values: Estimation rather than hypothesis testing. Br. Med. J. (Clin. Res. Educ.). 292:746-750.
25. Feuerstein, T. J. and Limberger, N. 1999. Mathematical analysis of the control of neurotransmitter release by presynaptic receptors as a supplement to experimental data. Naunyn Schmiedebergs Arch. Pharmacol. 359:345-359.
26. Furchgott, R. F. 1972. The classification of adrenoceptors (adrenergic receptors): An evaluation from the standpoint of receptor theory. Pages 283-335, in Blaschko, H. and Muscholl, E. (eds.), Handbook of Experimental Pharmacology, Vol. XXXIII, Springer, Berlin, Heidelberg, New York.
27. Tacke, R., Linoh, H., Zilch, H., Wess, J., Moser, U., Mutschler, E., and Lambrecht, G. 1985. Synthesis and properties of the selective antimuscarinic agent cyclohexylphenyl(3-piperidinopropyl)silanol. Liebigs Ann. Chem. 2223-2228.
28. Strittmatter, H., Jackisch, R., and Hertting, G. 1982. Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 321:195-200.
29. Gross, J., Mutschler, E., and Lambrecht, G. 1997. Evidence for muscarinic M4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle. Naunyn Schmiedebergs Arch. Pharmacol. 356:505-516.
30. Dörje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E., and Brann, M. R. 1991. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256:727-733.